Medicare Enrolled

Dr. Holly Caputy, O.D.

Optometrist · Aliquippa, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2576 BRODHEAD RD, Aliquippa, PA 15001
7243788585
In practice since 2012 (14 years)
NPI: 1235491200 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caputy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caputy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Caputy

Dr. Holly Caputy is an optometrist in Aliquippa, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Caputy performed 171 Medicare services across 152 unique beneficiaries.

Between the years covered by Open Payments, Dr. Caputy received a total of $6,414 from 27 pharmaceutical and/or device companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Caputy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 171 Medicare services $6,414 industry payments

Medicare Practice Summary

Medicare Utilization ↗
171
Medicare services
Bottom 35% in PA for optometrist
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
152
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
 64 $82 $140
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 49 $62 $89
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
 42 $52 $95
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
 16 $26 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,414
Total received (2018-2024)
Avg $916/year across 7 years
Top 4% in PA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
140
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,498 (54.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,916 (45.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$645
2023
$1,888
2022
$734
2021
$237
2020
$191
2019
$1,308
2018
$1,411

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$162
Apellis Pharmaceuticals, Inc.
$103
Johnson & Johnson Vision Care, Inc.
$86
LKC Technologies, Inc.
$72
Tarsus Pharmaceuticals, Inc.
$58
Harrow Eye, LLC
$50
Alcon Vision LLC
$41
Dompe US, Inc.
$27
Thea Pharma Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
CooperVision Inc.
$2,026
Bausch & Lomb, a division of Bausch Health US, LLC
$986
Alcon Laboratories Inc
$510
Johnson & Johnson Vision Care, Inc.
$431
Alcon Vision LLC
$396
Bausch & Lomb Americas Inc.
$335
Oyster Point Pharma, Inc.
$215
Shire North American Group Inc
$185
ABBVIE INC.
$162
Sun Pharmaceutical Industries Inc.
$149
Novartis Pharmaceuticals Corporation
$130
OPTOVUE, INC.
$129
GLAUKOS CORPORATION
$113
Allergan Inc.
$112
Apellis Pharmaceuticals, Inc.
$103
LKC Technologies, Inc.
$72
Tarsus Pharmaceuticals, Inc.
$58
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
Harrow Eye, LLC
$50
Kala Pharmaceuticals, Inc.
$40
ABB Con-Cise Optical Group LLC
$37
Dompe US, Inc.
$27
Thea Pharma Inc.
$23
TissueTech, Inc.
$19
EYEVANCE PHARMACEUTICALS LLC
$18
Allergan, Inc.
$17
AbbVie Inc.
$14
Top 3 companies account for 54.9% of all-time payments
Associated products mentioned in payments ›
Acuvue · BIOTRUE · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · Cequa · Clariti Contact Lens · Contact Lens · DAILIES · HYDRUS Microstent · INFUSE · INVELTYS · IYUZEH · KXL SYSTEM · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · MyDay Contact Lens · OXERVATE · Prokera · RESTASIS MULTIDOSE · Rocklatan · Syfovre · TYRVAYA · TobraDex ST · ULTRA · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · XR · ZYLET
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for optometrist in PA.

Looking for an optometrist in Aliquippa?
Compare optometrists in the Aliquippa area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
284
Per 100K population
170.1
County median income
$70,156
Nearest hospital
HERITAGE VALLEY BEAVER
7.4 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Caputy is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Caputy experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Caputy performed 64 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caputy receive payments from pharmaceutical companies?
Yes. Dr. Caputy received a total of $6,414 from 27 companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caputy's costs compare to other optometrists in Aliquippa?
Dr. Caputy's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caputy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Optometrists in Aliquippa
Browse optometrists in Aliquippa ranked by procedure volume and transparency data.
Highest volume
Top Optometrists in PA
Optometrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Optometrists in PA
Which PA optometrists receive the most from drug and device companies.
By company
CooperVision Inc. Payments to Doctors
See all physicians who received payments from CooperVision Inc.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
By company
Alcon Laboratories Inc Payments to Doctors
See all physicians who received payments from Alcon Laboratories Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →